What causes obesity, how does it lead to illness, and how does one tailor treatment to a patient’s personal situation? These are questions that the Obesity Center CGG at Erasmus MC is looking to answer.

Organoids made from liver tissue of patients with chronic hepatitis B already show the first molecular signs of liver cancer. This has been demonstrated by scientists at Erasmus MC and the the Hubrecht Organoid Technology (HUB).

Only 40 patients worldwide are known to have Barakat-Perenthaler syndrome, a severe untreatable form of epilepsy. Four years after discovering the disease, its Rotterdam namesakes are now on the trail of a treatment.

Researchers at Erasmus MC are able to keep slices of human heart tissue alive for several months in the laboratory. This enables them to test patient-specific treatments for heart failure and arrhythmia and possibly predict early rejection of donor hearts in the future.